Evidence map›Paper›PMID 41673422›Full record

ArticleScientific reports2026

A unified multi modal transformer framework for breast cancer recurrence prediction and survival analysis.

Saleem Malik, S Gopal Krishna Patro, Ahmed Kateb Jumaah Al-Nussairi, Chandrakanta Mahanty, Mohamed Ghouse, Akila Thiyagarajan, Ahmed Adnan Hadi, Anwar Khan, Mohit Mittal, Amanuel Zewude

Abstract read
PubMed Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saleem MalikCSE Department, P A College of Engineering, Mangalore, 574153, India. saleem_cs@pace.edu.in.
S Gopal Krishna PatroDepartment of Computer Science, Sreenidhi University, Hyderabad, Telangana, India.
Ahmed Kateb Jumaah Al-NussairiDean of the Technical Engineering College, University of Manara, Maysan, Iraq.
Chandrakanta MahantyDepartment of Computer Science & Engineering, GITAM Deemed to Be University, Visakhapatnam, 530045, India.
Mohamed GhouseDepartment of Computer Science, College of Computer Science, King Khalid University, Abha, Kingdom of Saudi Arabia.
Akila ThiyagarajanDepartment of Computer Science, College of Computer Science, King Khalid University, Abha, Kingdom of Saudi Arabia.
Ahmed Adnan HadiArtificial Intelligence Sciences Department, Al-Mustaqbal University, College of Sciences, 51001, Al Hillah, Babil, Iraq.
Anwar KhanDepartment of Electronics & Communication Engineering, Chandigarh University, Mohali, Punjab, India.
Mohit MittalDepartment of Data Science, Galgotias College of Engineering and Technology, Greater Noida, 201310, India.
Amanuel ZewudeSchool of Informatics and Computer Science, Dilla University, Po. Box 419, Dilla, Ethiopia. amanuelz@du.edu.et.

Funding

King Khalid University RGP1/141/46
6 · The paper itself

Abstract

Breast cancer recurrence prediction is an important feature of post-treatment therapy, requiring accurate identification of both recurrence risk and time-to-event outcomes. In this paper, we offer a unified deep learning system that jointly performs survival analysis and multi-class recurrence classification, enabling full risk stratification for breast cancer patients. The proposed model includes a Transformer-based survival module to estimate time-until-recurrence, and an attention-guided classification module to differentiate between second primary cancer, low-risk, and high-risk recurrence instances. A multi-modal dataset comprising clinical, molecular, demographic, and lifestyle data is created from established sources like METABRIC, GSE2034, GSE2990, BCSC, and the Breast Cancer Coimbra dataset. The model uses cross-modal feature fusion, autoencoder-based dimensionality reduction, and attention-based feature attribution for applicability and accessibility. Experimental results show better accuracy, precision, recall, and F1-score of 99.12%, 98.75%, 99.08%, and 98.91%, outperforming standard machine learning and survival models. This unified paradigm gives doctors a powerful, interpretable tool for early intervention and personalized breast cancer treatment.

Indexed as

Breast NeoplasmsDeep LearningNeoplasm Recurrence, LocalClassification AlgorithmsFemaleHumansPrediction AlgorithmsPredictive Learning ModelsPrognosisSurvival AnalysisBreast cancer predictionDeep learningSurvival analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.